Retina/Vitreous News

WAILEA, Hawaii — In this Healio Video Perspective from Retina 2024, Jordan M. Graff, MD, FACS, describes a post hoc analysis of the YOSEMITE and RHINE clinical trials evaluating biomarkers for vascular stability.

In this Healio Video Perspective from the Macula Society meeting, Dilsher Dhoot, MD, discusses data from three phase 3 trials involving pegcetacoplan and avacincaptad pegol for the treatment of geographic atrophy.

Chronic kidney disease and compromised kidney function were significantly associated with late age-related macular degeneration, according to a pooled analysis of 10 Asian-based studies.

Lesion-level analysis on OCT can help identify risk for atrophy, according to a speaker at Angiogenesis, Exudation, and Degeneration 2024.

Ocular Therapeutix announced that the first three participants have received an aflibercept injection in the phase 3 SOL-1 clinical trial of Axpaxli, an axitinib intravitreal implant for wet age-related macular degeneration.

WAILEA, Hawaii — In this Healio Video Perspective from Retina 2024, Samuel A. Minaker, MD, discusses the 0.19 mg fluocinolone acetonide implant for diabetic macular edema.

Continuous growth of macular neovascularization size, as well as development of outer retina atrophy, was observed in neovascular age-related macular degeneration, even with frequent anti-VEGF treatment, according to research in PLoS One.

Opthea Limited has completed enrollment of its COAST phase 3 clinical trial, a study of sozinibercept in combination with Eylea for wet age-related macular degeneration, the company announced in a press release.

Restoret showed promising safety and efficacy results at 12 weeks in patients with treatment-naive diabetic macular edema and treatment-naive neovascular age-related macular degeneration, according to a press release from EyeBio.

Adherence to intravitreal anti-VEGF injections may be challenging for some patients with neovascular age-related macular degeneration, putting them at risk for poor vision outcomes, according to research published in Ophthalmology Science.